1. Home
  2. ASMB vs STIM Comparison

ASMB vs STIM Comparison

Compare ASMB & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • STIM
  • Stock Information
  • Founded
  • ASMB 2005
  • STIM 2003
  • Country
  • ASMB United States
  • STIM United States
  • Employees
  • ASMB N/A
  • STIM N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • STIM Medical/Dental Instruments
  • Sector
  • ASMB Health Care
  • STIM Health Care
  • Exchange
  • ASMB Nasdaq
  • STIM Nasdaq
  • Market Cap
  • ASMB 84.5M
  • STIM 192.0M
  • IPO Year
  • ASMB 2010
  • STIM 2018
  • Fundamental
  • Price
  • ASMB $13.30
  • STIM $3.86
  • Analyst Decision
  • ASMB Buy
  • STIM Buy
  • Analyst Count
  • ASMB 2
  • STIM 4
  • Target Price
  • ASMB $35.00
  • STIM $4.67
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • STIM 1.8M
  • Earning Date
  • ASMB 03-27-2025
  • STIM 03-04-2025
  • Dividend Yield
  • ASMB N/A
  • STIM N/A
  • EPS Growth
  • ASMB N/A
  • STIM N/A
  • EPS
  • ASMB N/A
  • STIM N/A
  • Revenue
  • ASMB $28,326,000.00
  • STIM $72,711,000.00
  • Revenue This Year
  • ASMB $282.16
  • STIM $3.23
  • Revenue Next Year
  • ASMB N/A
  • STIM $29.55
  • P/E Ratio
  • ASMB N/A
  • STIM N/A
  • Revenue Growth
  • ASMB N/A
  • STIM 5.03
  • 52 Week Low
  • ASMB $11.01
  • STIM $0.52
  • 52 Week High
  • ASMB $19.93
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • STIM 69.56
  • Support Level
  • ASMB $13.13
  • STIM $2.80
  • Resistance Level
  • ASMB $14.25
  • STIM $3.65
  • Average True Range (ATR)
  • ASMB 0.55
  • STIM 0.42
  • MACD
  • ASMB -0.07
  • STIM 0.04
  • Stochastic Oscillator
  • ASMB 15.38
  • STIM 94.92

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: